Haemonetics Corp.

NYSE: HAE
Share price (4/26/24): $90.99
Market cap (4/26/24): $4.621 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

16 Haemonetics Corp. Expert Interviews, now on BamSEC.

Powered by Tegus.

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K/A 93 pages Certain Information Has Been Omitted From This Document Because It Is Not Material, Is the Type That Haemonetics Corporation Treats as Confidential and Would Be Competitively Harmful if Publicly Disclosed. Omissions Are Marked [***]. Haemonetics Corporation and 9500-7704 Québec Inc. and Opsens Inc. Arrangement Agreement October 10, 2023

from 8-K/A 1 page Plan of reorganization, merger, acquisition or similar

from 8-K/A ~5 pages Plan of reorganization, merger, acquisition or similar

from 8-K/A ~20 pages Plan of reorganization, merger, acquisition or similar

from 8-K ~50 pages Ex 2.1-Agreement and Plan of Merger Dated 9-4-2000